Summary

This document contains information about dementia drugs, focusing on Alzheimer's treatment, behavioral symptoms, and treatment strategies. It presents information in question-and-answer format.

Full Transcript

\#\#\# Slide 24 - Another Approach: Caprylidene 1\. \*\*What is the primary purpose of Caprylidene in Alzheimer\'s treatment?\*\* \- A) Reduce amyloid plaques \- B) Enhance acetylcholine transmission \- C) Provide ketone bodies for energy \- D) Block NMDA receptors \*\*Answer\*\*: C) Provide k...

\#\#\# Slide 24 - Another Approach: Caprylidene 1\. \*\*What is the primary purpose of Caprylidene in Alzheimer\'s treatment?\*\* \- A) Reduce amyloid plaques \- B) Enhance acetylcholine transmission \- C) Provide ketone bodies for energy \- D) Block NMDA receptors \*\*Answer\*\*: C) Provide ketone bodies for energy 2\. \*\*In Alzheimer's patients, glucose uptake in the brain is often impaired. What alternative energy source does Caprylidene provide?\*\* \- A) Lactate \- B) Ketone bodies \- C) Free fatty acids \- D) Glycogen \*\*Answer\*\*: B) Ketone bodies 3\. \*\*Which diagnostic tool is used to identify decreased glucose uptake in Alzheimer's patients, prompting the use of Caprylidene?\*\* \- A) EEG \- B) MRI \- C) PET scan \- D) CT scan \*\*Answer\*\*: B) MRI \#\#\# Slide 25 - Alzheimer's Disease Behavioral Symptoms 4\. \*\*Which of the following is a common behavioral symptom in advanced Alzheimer's disease?\*\* \- A) Hyperactivity \- B) Agitation \- C) Anhedonia \- D) Sleepwalking \*\*Answer\*\*: B) Agitation 5\. \*\*Which pharmacologic treatment is typically used for agitation in Alzheimer\'s patients?\*\* \- A) SSRIs like Citalopram \- B) Benzodiazepines like Diazepam \- C) Anticholinergics \- D) MAO inhibitors \*\*Answer\*\*: A) SSRIs like Citalopram 6\. \*\*Which atypical antipsychotic is commonly prescribed to manage psychosis in Alzheimer's disease?\*\* \- A) Risperidone \- B) Fluoxetine \- C) Lorazepam \- D) Valproate \*\*Answer\*\*: A) Risperidone \#\#\# Slide 28 - Alzheimer\'s Disease Treatment 1\. \*\*What is the most commonly used drug class for cognitive enhancement in Alzheimer\'s disease?\*\* \- A) Dopamine agonists \- B) NMDA receptor antagonists \- C) Cholinesterase inhibitors \- D) GABA receptor agonists \*\*Answer\*\*: C) Cholinesterase inhibitors 2\. \*\*At which stage of Alzheimer\'s disease is Memantine typically added to treatment?\*\* \- A) Early stage \- B) Mild cognitive impairment \- C) Moderate to severe stages \- D) Asymptomatic stage \*\*Answer\*\*: C) Moderate to severe stages 3\. \*\*Which type of medications should be eliminated in Alzheimer\'s disease treatment due to their adverse cognitive effects?\*\* \- A) Sedative-hypnotics \- B) SSRIs \- C) Anticholinergics \- D) MAO inhibitors \*\*Answer\*\*: C) Anticholinergics \#\#\# Slide 29 - Rationale for Multi-Factorial Approach 4\. \*\*Which of the following is NOT a recommended strategy for optimizing brain health in Alzheimer\'s patients?\*\* \- A) Physical exercise \- B) Heavy metal toxicity management \- C) Avoiding supplements \- D) Stress management \*\*Answer\*\*: C) Avoiding supplements 5\. \*\*Which lifestyle factor is crucial for managing insulin resistance in Alzheimer's disease patients?\*\* \- A) Cognitive stimulation \- B) Physical exercise \- C) Dietary restrictions \- D) Sleep \*\*Answer\*\*: B) Physical exercise 6\. \*\*What type of toxicity is addressed as part of the multi-factorial approach to brain health in Alzheimer's patients?\*\* \- A) Viral toxicity \- B) Heavy metal toxicity \- C) Radiation toxicity \- D) Alcohol toxicity \*\*Answer\*\*: B) Heavy metal toxicity 1\. \*\*What is the most common method of assessing cognitive decline in Alzheimer's patients?\*\* \- A) Montreal Cognitive Assessment (MoCA) \- B) ADAS-Cog \- C) MMSE \- D) CIBIC \*\*Answer\*\*: C) MMSE 2\. \*\*What are the primary types of biomarkers used in diagnosing Alzheimer\'s disease?\*\* \- A) MRI and blood glucose \- B) PET scans and tau protein levels in CSF \- C) Liver enzyme tests and cholesterol levels \- D) ECG and heart rate \*\*Answer\*\*: B) PET scans and tau protein levels in CSF 3\. \*\*Which of the following imaging techniques is commonly used to detect hippocampal atrophy in Alzheimer's disease?\*\* \- A) MRI \- B) X-ray \- C) Ultrasound \- D) CT scan \*\*Answer\*\*: A) MRI

Use Quizgecko on...
Browser
Browser